Furthermore, we investigated the correlation between TRAIL and PD-L1 and found that TRAIL upregulates PD-L1 expression through the STAT3/ERK signaling pathway, further inducing EMT and tumor progression in ESCC. Here, STAT3 is linked to esophageal squamous cell carcinoma.